EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
EU Regulators Quiz Novo Nordisk, Catalent Rivals on $16.5 Billion Deal
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
EU regulators see info from rivals, customers in Catalent sale to Novo Holdings - Reuters
European Union seeks input from rival pharmaceutical firms on Novo Holdings' $16.5 billion acquisition of Catalent.
bovnews6d
What’s Causing Catalent Inc (CTLT) Stock’s 6.45% Jump Over the Last Six Months?
On Friday, Catalent Inc (CTLT) stock saw a decline, ending the day at $59.41 which represents a decrease of $-0.51 or -0.85% from the prior close of $59.92. The stock opened at $59.81 and touched a ...
devdiscourse1d
Global Health: Big Pharma Deals, Diabetes Epidemic, and Opioid Cases
A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...
Yahoo Finance1d
Catalent, Inc. (CTLT)
SOMERSET, N.J., November 05, 2024--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial results for the ...
devdiscourse1d
Innovations and Challenges in Pharma: A Global Health Report
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
FiercePharma2d
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
The fragrances successful men are wearing this year, from expensive Le Labo colognes to Old Spice deodorant
Fragrances are skyrocketing in popularity. Successful men, in particular, love luxury colognes from brands like Le Labo and ...